Morphogenesis — Florida-based immunotherapy company — and the Cell and Gene Therapy Group at Karolinska Institutet (KI) in Sweden have announced a collaboration for the development of targeted immunotherapies to treat cancer. Morphogenesis, Inc., a Tampa, FL-based immunotherapy company, and ...
Read More »Aethlon Medical Receives Expedited Access Pathway Designation from FDA for the Hemopurifier®
Aethlon Medical, Inc, a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that it has received an Expedited Access Pathway (EAP) designation from the United States Food and Drug Administration (FDA) to support the ...
Read More »Biocept and UT Southwestern Announce Liquid Biopsy Clinical Study to Profile Lung Cancer Patients
Biocept, Inc. a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces it has entered into a clinical study agreement with the University of Texas Southwestern Medical Center ...
Read More »Investors Watch List – Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) belongs to Healthcare sector. Its weekly performance is -2.50%. On last trading day company shares ended up $4.68. Capricor Therapeutics, Inc. (NASDAQ:CAPR) distance from 50-day simple moving average (SMA50) is -22.39%. On 17 June, Capricor Therapeutics, ...
Read More »Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes
Viable tumor cells actively release vesicles into the peripheral circulation and other biologic fluids, which exhibit proteins and RNAs characteristic of that cell. Researchers from Exosome Sciences, Inc demonstrated the presence of these extracellular vesicles of tumor origin within the peripheral ...
Read More »Aethlon Medical and Exosome Sciences Announce Brain Research Discoveries
Discoveries Could Have Implications in the Diagnosis, Monitoring and Treatment of Alzheimer’s Disease, Chronic Traumatic Encephalopathy and Traumatic Brain Injury SAN DIEGO, March 5, 2014 /PRNewswire/ — Aethlon Medical, Inc. (otcqx:AEMD), and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), announced today ...
Read More »